CLINICAL_TRIALS
trial_result
· 2020-08-07
Clinical Trial Update: Single-Arm Study of the Efficacy and Safety of Oral Rigosertib in Patients With Myelofibrosis (MF) and Anemia [Phase 2]
Summary
Phase 2 single-arm trial evaluating oral rigosertib in myelofibrosis with anemia was terminated; results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: M.D. Anderson Cancer Center | Conditions: Leukemia, Myelofibrosis | Phase 2 | Status: TERMINATED | Results posted: 2020-08-07